Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Lung Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT07366658 2026-01-26

NEUK203-13

Phase 1 Not yet recruiting

9 enrolled

EndocrineNET

Neuroendocrine Tumors

NCT05608148 2025-11-18

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Phase 1 Recruiting

61 enrolled

CNSOther solid neoplasm

Refractory/Relapse Neuroblastoma

NCT06348719 2025-09-15

ROBOT-ECO-GYN

Phase NA Recruiting

1,680 enrolled

Gynecologic

Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma

NCT05884983 2025-08-15

Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma

Recruiting

12,000 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT05843539 2025-07-22

CAPONE

Completed

100 enrolled

Breast

Breast Neoplasms

NCT01430390 2025-06-11

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Phase 1 Active not recruiting

19 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06144762 2025-02-12

PANC-O-MICS

Phase NA Recruiting

150 enrolled

GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms

NCT02828202 2025-02-11

MelBase

Recruiting

6,000 enrolled

Dermatologic

Melanoma

NCT06777264 2025-01-15

JUVENTAS-ALL05

Phase 2 Not yet recruiting

20 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03549000 2024-12-13

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Phase 1 Terminated

127 enrolled

BreastGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT04283539 2023-11-13

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

Unknown

238 enrolled

Tumor-Agnostic

Neoplasms

NCT00014131 2023-10-04

Vaccine Therapy in Treating Patients With Kidney Cancer

Phase 1 Terminated

9 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04382352 2023-03-24

B002-101

Phase 1 Completed

23 enrolled

Breast

Breast Neoplasms

NCT02529930 2022-07-13

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Phase 1/2 Completed

34 enrolled

Gynecologic

High Grade Cervical Intraepithelial Neoplasia

NCT04436133 2022-05-06

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

Phase 2 Completed

480 enrolled

Papillomavirus Infections

NCT02128230 2021-06-22

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Phase 2 Terminated

20 enrolled 7 charts

Plasma cell

Multiple Myeloma

NCT01413087 2019-11-01

LAPC-BC-819

Phase 2 Terminated

12 enrolled 19 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT03383952 2017-12-27

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

Phase 1 Unknown

20 enrolled

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT03383965 2017-12-27

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

Phase 1 Unknown

20 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic

NCT01974869 2017-02-07

Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response

Completed

47 enrolled

Inflammatory Bowel Diseases

NCT02806934 2016-06-21

TNF Polymorphism and Implantation Rate

Completed

120 enrolled

Infertility

NCT01349647 2016-01-05

Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid

Phase 1 Completed

21 enrolled

Thoracic

Lung Neoplasms

NCT01250314 2012-07-03

OSTEHOM

Phase NA Completed

79 enrolled

Endocrine

Osteoporosis, Multiple Endocrine Neoplasia Type 1

Clinical Trials

A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1

NEUK203-13

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

ROBOT-ECO-GYN

Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma

CAPONE

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

PANC-O-MICS

MelBase

JUVENTAS-ALL05

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

Vaccine Therapy in Treating Patients With Kidney Cancer

B002-101

An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3)

Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)

UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

LAPC-BC-819

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas

Anti Tumor Necrosis Factor Alpha Agents and Surgical Stress Response

TNF Polymorphism and Implantation Rate

Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid

OSTEHOM